«Finnish Aidian has built a globally leading position in point-of-care diagnostics. The company’s instruments and tests are an important part of the solution to meet global health challenges. Together with the majority shareholder Nordstjernan, we want to develop the company’s position as a leading European diagnostic player in point-of-care diagnostics and analysis,” says CEO of Ferd, Morten Borge.
Earlier this year, the Swedish family-controlled investment company Nordstjernan bought 100% of the shared In Aidian. Ferd now buys 33% of the shares and thus enters as a minority owner.
«We are delighted to have Ferd as a partner in Aidian’s further development and growth. Nordstjernan and Ferd have a lot in common, both being family-controlled companies that think long-term about our investments. In addition, we both see great potential in the health sector,” says the CEO of Nordstjernan, Peter Hofvenstam.
The parties have agreed that the terms of the transaction will not be published.
Contact information:
Ferd AS:
Morten Borge, CEO
Tlf: +47 90169291
Nordstjernan AB:
Stefan Stern
Tlf:: +46 70 636 74 17